Gene Therapy

Aldevron, Nature Technology Corporation Team Up to Offer Nanoplasmids™ for Gene Therapy Manufacturing

FARGO, N.D. (October 22, 2019) – Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing.  Through a license agreement with Nature Technology Corporation (NTC), Aldevron can now provide its clients the option of using NTC’s plasmid technology to provide a more efficient system for manufacturing viral […]

EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies

EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journey EQT will support Aldevron through investments in additional production capacity, R&D, and growth initiatives and by leveraging EQT’s strong healthcare expertise, global presence, and network of Industrial Advisors New York, NY – July […]

Bio-Techne China Recognized With “Decade of Contribution Award”

 Minneapolis, June 26, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the “Decade of Contribution Award” at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne’s team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry.  The 2019 (10th) […]

Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus

August ground breaking of second GMP manufacturing facility Expands GMP and GMP SourceTM plasmid capacity 10-fold Supports gene editing, gene therapy, and cell therapy applications Includes synthetic production of nucleic acids, vertical integration for clients FARGO, N.D. (June 3, 2019) – Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies; announced […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER